SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark unveils its Strategic Blueprint on innovative NME

19 Dec 2016 Evaluate

Glenmark Pharmaceuticals (GPL), has unveiled its Strategic Blueprint to transition into an Innovation?led Global Pharmaceutical Organization over the next decade. The Blueprint conveys the company’s greater business alignment expanding generics to prioritizing research and development efforts in three key therapeutic areas: oncology, respiratory and dermatology.

The innovative oncology pipeline, with candidates targeting multiple tumors, is the top priority with the greater promise to deliver novel, first?in?class molecules and help company evolve into a fully commercialized, innovation?led pharmaceutical company. The strategic blueprint also outlines aggressive plans to increase company’s presence worldwide by strengthening focus on complex generics including injectables, expanding its manufacturing footprint (growing from two formulation facilities to 17).

Glenmark’s current portfolio consists of 109 products authorized for distribution in the US marketplace and 62 ANDA’s pending approval with the US FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharma Share Price

2373.75 0.00 (0.00%)
07-May-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1835.25
Dr. Reddys Lab 1306.55
Cipla 1362.95
Zydus Lifesciences 941.35
Lupin 2455.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×